<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/FE3DED02-2377-4B6E-855D-93A9785D067A"><gtr:id>FE3DED02-2377-4B6E-855D-93A9785D067A</gtr:id><gtr:firstName>Paula</gtr:firstName><gtr:surname>Da Fonseca</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UP_1201%2F5"><gtr:id>CD940E9C-B8F1-4240-A966-9C4FF6173B68</gtr:id><gtr:title>Structure and Function of Cell Regulatory Protein Complexes</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UP_1201/5</gtr:grantReference><gtr:abstractText>The functioning and division of all cells, from all kingdoms of life, are tightly regulated by highly specialised protein complexes. These are assemblies of proteins that together accurately coordinate, and respond to, specific signals including those leading each cell to divide. In humans the malfunction of these complexes is implicated in a wide range of medical conditions. These include cancer, where cells lose their ability to regulate their division and multiply uncontrollably, while accumulating malfunctions. 
We use high resolution electron microscopy to record images of regulatory protein complexes, which we prepare in the laboratory. The computational analysis of such images, by methods known as single particle analysis, is used to visualise these complexes in three-dimensions with intricate details. These studies reveal how the different components of protein complexes are organised and how they function together to generate the regulatory properties of the complex itself. Ultimately, the understanding of how these complexes are organised and how they work in normal and diseased cells should provide fundamental information that can be used in the development of new improved medicines to efficiently fight serious illnesses, with reduced unwanted side effects.</gtr:abstractText><gtr:technicalSummary>Our work focus on determining the structure and function of cell regulatory protein complexes primarily by electron cryo-microscopy (cryo-EM) based methods. Cell homeostasis is critically regulated by highly specialised macromolecular protein complexes that accurately coordinate specific signals both in time and intracellular location. Deregulation of the function of such complexes is associated with a wide range of medical conditions including cancer. By achieving an understanding of the structural organisation and functional mechanisms of protein complexes critical for cellular function, our work provides a strong framework to understand how the deregulation of these complexes results in disease and should allow the identification of how they can be specifically modulated as therapeutic targets. 
The latest revolution in the field of cryo-EM has made it suitable to determine protein structures at resolutions that until recently would only be attainable by X-ray crystallography or NMR methods. High resolution cryo-EM has the advantages of allowing the analysis of proteins maintained closer to physiological conditions and also requires significantly smaller amounts of purified protein than normally needed for other methods of protein structure determination. Our work relies on the state-of-the-art electron microscopy facility at the MRC Laboratory of Molecular Biology and the production of high quality samples, combined with their biophysical characterisation to facilitate the interpretation of the structural maps obtained, as required.
Currently we aim at fully understanding the molecular mechanisms of the mammalian 26S proteasome. The proteasome is a large ATP dependent protease complex, formed by at least 32 individual subunits, essential in all eukaryotes. Apart from its role in general proteostasis, the proteasome is responsible for the highly regulated degradation of proteins the removal of which signals for fundamental processes such as cell cycle progression and the regulation of gene transcription. The proteasome is a well-established target for cancer therapy since its inhibition induces apoptosis primarily of fast-dividing cells. Second generation proteasome inhibitors are currently used in the treatment of multiple myeloma. Additionally, proteasome inhibition is also being explored as a therapeutic target for other varied conditions such as inflammatory disorders and viral infections, and our recent work contributed to validate the Plasmodium falciparum proteasome as a target for antimalarials. While the overall structural organisation of the 26S proteasome subunits is known, the understanding of its detailed functional mechanisms remains significantly elusive. The complete understanding of these mechanisms is fundamental to clarifying the full role the proteasome plays in the human cells, and how its activity can be efficiently modulated as a therapeutic target, with minimal side effects.</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-01-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>912280</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Cambridge Science Festival</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>CC9295E9-B0BC-42FE-AD18-C3069D73A163</gtr:id><gtr:impact>The demonstrations created reactions of amazement, raised curiosity and questions

raised awareness of the power of protein crystallography for the understanding of the mechanisms of life</gtr:impact><gtr:outcomeId>54620e263fc3f3.74745979</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www2.mrc-lmb.cam.ac.uk/over-50-lmb-scientists-showcase-research-at-the-cambridge-science-festival/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>04ECA6A1-CC49-4E5A-B825-65DADEC72845</gtr:id><gtr:title>Structure- and function-based design of Plasmodium-selective proteasome inhibitors.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08e3e9b152d63bb3495d9a000cd75f74"><gtr:id>08e3e9b152d63bb3495d9a000cd75f74</gtr:id><gtr:otherNames>Li H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56d080c8d029a0.79992101</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3838A035-31CF-4AC4-96F7-5AF8BDAB450D</gtr:id><gtr:title>Structure of the Human 26S Proteasome</gtr:title><gtr:parentPublicationTitle>Microscopy and Microanalysis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4371106ab48483ee5a1d637fd5b58b2f"><gtr:id>4371106ab48483ee5a1d637fd5b58b2f</gtr:id><gtr:otherNames>da Fonseca P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>cEyJ2yw72L5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>399E2F0A-35FC-45D1-8085-0590D4CAB528</gtr:id><gtr:title>The cryo-EM structure of the Plasmodium falciparum 20S proteasome and its use in the fight against malaria.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08e3e9b152d63bb3495d9a000cd75f74"><gtr:id>08e3e9b152d63bb3495d9a000cd75f74</gtr:id><gtr:otherNames>Li H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>585d39956eac20.79318366</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8825D93-D09F-4058-84F5-9DB7BB879650</gtr:id><gtr:title>Cryo-EM reveals the conformation of a substrate analogue in the human 20S proteasome core.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26a28bc68082bc0f0c57b064d6e7096d"><gtr:id>26a28bc68082bc0f0c57b064d6e7096d</gtr:id><gtr:otherNames>da Fonseca PC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56c48fc7e4ccb5.20322658</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>752ABE0F-8180-4E38-91AF-8917EF9D8BDB</gtr:id><gtr:title>High-resolution cryo-EM proteasome structures in drug development.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section D, Structural biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef39daec7b9e1d6ad7810ef8347d370d"><gtr:id>ef39daec7b9e1d6ad7810ef8347d370d</gtr:id><gtr:otherNames>Morris EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2059-7983</gtr:issn><gtr:outcomeId>5a86f9e0d89a37.69815148</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UP_1201/5</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>